Concepedia
Statistics
Publications
12
Citations
317
H-Index
Active since
1984
Affiliations
Semmelweis University(Current)
Hungarian Academy of Sciences
National Institute of Oncology
Ágnes Márk is an author at Semmelweis University specializing in oncology, molecular oncology, and medicine.
Publications per year
1984–2021
Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia
Karolina Nemes, Monika Csóka, Noémi Nagy et al. · Pathology & Oncology Research · 2014 · 56 citations
Medicine, Molecular Biology, Oncology +14
Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study
Ágnes Márk, Melinda Hajdú, Zsófia Váradi et al. · BMC Cancer · 2013 · 39 citations · Full text
Medicine, Oncology, Pharmacology +14
The Activated Targets of mTOR Signaling Pathway Are Characteristic for PDGFRA Mutant and Wild-type Rather Than KIT Mutant GISTs
Zoltàn Sápi, Tibor Füle, Melinda Hajdu et al. · Diagnostic Molecular Pathology · 2011 · 31 citations
Medicine, Oncology, Pathology +17
Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma
Ildikó Krencz, Anna Sebestyén, Katalin Fábián et al. · Human Pathology · 2016 · 31 citations
Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)
Karolina Nemes, Anna Sebestyén, Ágnes Márk et al. · PLoS ONE · 2013 · 27 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12